Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREV-CART: Immunoglobulin Replacement Therapy vs Antibiotic Prophylaxis in CAR-T Treated Patients
NCT07754682Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2026
- Primary completion
- Sep 2029
01
Overview
A Phase 3 trial of polyvalent human immunoglobulin in secondary antibody deficiency, Infection, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
secondary antibody deficiencyInfection
Beyond the preview
Go deeper on NCT07754682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07754682.